ENTRY       D05343                      Drug
NAME        Palonosetron hydrochloride (JAN/USP);
            Aloxi (TN)
PRODUCT     PALONOSETRON HYDROCHLORIDE (West-Ward Pharmaceuticals Corp)
  GENERIC   PALONOSETRON (Apotex Corp.)
            PALONOSETRON (BluePoint Laboratories)
            PALONOSETRON (Dr.Reddy's Laboratories Limited)
            PALONOSETRON (Fresenius Kabi USA)
            PALONOSETRON (Fresenius Kabi USA)
            PALONOSETRON (NorthStar Rx LLC)
            PALONOSETRON (Qilu Pharmaceutical)
            PALONOSETRON HYDROCHLORIDE (Athenex Pharmaceutical Division)
            PALONOSETRON HYDROCHLORIDE (Baxter Healthcare Corporation)
            PALONOSETRON HYDROCHLORIDE (Cipla USA)
            PALONOSETRON HYDROCHLORIDE (Cipla USA)
            PALONOSETRON HYDROCHLORIDE (Eugia US LLC)
            PALONOSETRON HYDROCHLORIDE (Hospira)
            PALONOSETRON HYDROCHLORIDE (Meitheal Pharmaceuticals)
            PALONOSETRON HYDROCHLORIDE (Mylan Institutional LLC)
            PALONOSETRON HYDROCHLORIDE (Sagent Pharmaceuticals)
            PALONOSETRON HYDROCHLORIDE (Sandoz)
            PALONOSETRON HYDROCHLORIDE (Sandoz)
            PALONOSETRON HYDROCHLORIDE (Teva Parenteral Medicines)
            PALONOSETRON HYDROCHLORIDE (Virtus Pharmaceuticals)
FORMULA     C19H24N2O. HCl
EXACT_MASS  332.1655
MOL_WEIGHT  332.8676
CLASS       Gastrointestinal agent
             DG01489  5-HT3-receptor antagonist
             DG01762  Antiemetic
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2391
            ATC code: A04AA05
            Chemical structure group: DG00064
            Product (DG00064): D05343<JP/US>
            Product (mixture): D10572<US>
EFFICACY    Anti-emetic, Serotonin 5-HT3 receptor antagonist
TARGET      HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]
  PATHWAY   hsa04726(170572+200909+285242+3359+9177)  Serotonergic synapse
METABOLISM  Enzyme: CYP1A2 [HSA:1544], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A04 ANTIEMETICS AND ANTINAUSEANTS
               A04A ANTIEMETICS AND ANTINAUSEANTS
                A04AA Serotonin (5HT3) antagonists
                 A04AA05 Palonosetron
                  D05343  Palonosetron hydrochloride (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antiemetics
              Emetogenic Therapy Adjuncts
               Palonosetron
                D05343  Palonosetron hydrochloride (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              23  Digestive organ agents
               239  Miscellaneous
                2391  Antiemetics
                 D05343  Palonosetron hydrochloride (JAN/USP)
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01489  5-HT3-receptor antagonist
               DG00064  Palonosetron
                D05343  Palonosetron hydrochloride
              DG01762  Antiemetic
               DG00064  Palonosetron
                D05343  Palonosetron hydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00064  Palonosetron
                D05343  Palonosetron hydrochloride
              DG01644  CYP2D6 substrate
               DG00064  Palonosetron
                D05343  Palonosetron hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00064  Palonosetron
                 D05343  Palonosetron hydrochloride
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               Serotonin
                HTR3
                 D05343  Palonosetron hydrochloride (JAN/USP) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05343
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05343
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05343
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05343
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D05343
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D05343
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01489  5-HT3-receptor antagonist
               DG00064  Palonosetron
              DG01762  Antiemetic
               DG00064  Palonosetron
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00064  Palonosetron
              DG01644  CYP2D6 substrate
               DG00064  Palonosetron
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00064  Palonosetron
DBLINKS     CAS: 135729-62-3
            PubChem: 47207029
            ChEBI: 85157
            LigandBox: D05343
ATOM        23
            1   N1y N    31.1604  -19.2289
            2   C5x C    32.5639  -19.2289
            3   C8y C    33.2656  -18.0359
            4   C8y C    32.5639  -16.8429
            5   C1y C    31.1604  -16.8427
            6   C1x C    30.4586  -17.9657
            7   C8y C    33.2656  -15.6499
            8   C1x C    32.5639  -14.3868
            9   C1x C    31.2306  -14.3868
            10  C1x C    30.5288  -15.5798
            11  C8x C    34.6691  -18.0359
            12  C8x C    35.3709  -16.8429
            13  C8x C    34.6691  -15.6499
            14  O5x O    33.2656  -20.4218
            15  C1y C    29.6867  -18.6675
            16  C1x C    29.0551  -19.6499
            17  N1y N    27.5814  -18.8078
            18  C1x C    27.5814  -17.5447
            19  C1x C    26.0376  -19.5797
            20  C1y C    28.3534  -17.7552
            21  C1x C    28.3534  -16.7727
            22  C1x C    26.7393  -18.4569
            23  X   Cl   37.2656  -18.5271
BOND        26
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    3  11 1
            13   11  12 2
            14   12  13 1
            15   13   7 2
            16    2  14 2
            17   16  17 1
            18   16  15 1
            19   17  18 1
            20   17  19 1
            21   15  20 1
            22   18  21 1
            23   19  22 1
            24   20  21 1
            25   20  22 1
            26   15   1 1 #Down
///
